References
Hassanein AH, Mulliken JB, Fishman SJ, Quatrano NA, Zurakowski D, Greene AK. Lymphatic malformation: risk of progression during childhood and adolescence J Craniofac Surg 2012, 23: 149–52.
Banziger-Tobler NE, Halin C, Kajiya K, Detmar M. Growth hormone promotes lymphangiogenesis. Am J Pathol 2008, 173: 586–97.
Kulungowski AM, Hassanein AH, Nosé V, et al. Expression of androgen, estrogen, progesterone, and growth hormone receptors in vascular malformations Plast Reconstr Surg 2012, 129: 919e–24e.
Lee J, Kong MS. Primary intestinal lymphangiectasia diagnosed by endoscopy following the intake of a high fat meal. Eur J Pediatr 2008, 167: 237–9.
MacLean JE, Cohen E, Weinstein M. Primary intestinal and thoracic lymphangiectasia: a response to antiplasmin therapy. Pediatrics 2002, 109: 1177–80.
Dierselhuis MP, Boelens JJ, Versteegh FG, Weemaes C, Wulffraat NM. Recurrent and opportunistic infections in children with primary intestinal lymphangiectasia. J Pediatr Gastroenterol Nutr 2007, 44: 382–5.
Sari S, Baris Z, Dalgic B. Primary intestinal lymphangiectasia in children: is octreotide an effective and safe option in the treatment? J Pediatr Gastroenterol Nutr 2010, 51: 454–7.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Salpietro, V., Ruggieri, M., Alterio, T. et al. Is there a risk of pubertal worsening in primary intestinal lymphangiectasia?. J Endocrinol Invest 36, 1128 (2013). https://doi.org/10.3275/8974
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.3275/8974